Recombinant Mouse VEGF120 Protein(HEK293)

Vascular Endothelial Growth Factor 120 (VEGF120) is a potent angiogenic factor that plays a critical role in the regulation of blood vessel formation. Understanding its biological functions and mechanisms of action has significant implications in both physiological and pathological conditions, such as cancer, ischemia, and inflammatory diseases. While several isoforms of VEGF exist, VEGF120 is notable because it lacks certain heparin-binding domains that are present in other isoforms, leading to a unique profile in promoting endothelial cell proliferation and migration. Recent studies have focused on the recombinant production of VEGF120 to explore its functional properties further and its potential therapeutic applications. The use of recombinant technology allows for the generation of high-purity VEGF120, facilitating detailed investigations into its signaling pathways and interactions with other growth factors. Additionally, research into VEGF120 may contribute to the development of targeted therapies aimed at modulating angiogenesis and improving treatment outcomes in various disorders characterized by abnormal vascular growth. By elucidating the roles of VEGF120 in both health and disease, researchers aim to harness its properties for innovative therapeutic interventions, addressing unmet medical needs in areas such as tumor vascularization and wound healing. As a result, VEGF120 has emerged as a focal point in angiogenesis research, offering valuable insights into the complexities of vascular biology and its implications for clinical applications.